INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 63 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $346,555 | -83.0% | 10,960 | -78.1% | 0.00% | -83.3% |
| Q2 2023 | $2,042,179 | +47.2% | 50,078 | +34.5% | 0.02% | +38.5% |
| Q1 2023 | $1,387,447 | +12.7% | 37,227 | +69.4% | 0.01% | +30.0% |
| Q3 2022 | $1,231,000 | -47.0% | 21,970 | -51.1% | 0.01% | -56.5% |
| Q2 2022 | $2,324,000 | +33.9% | 44,900 | +87.9% | 0.02% | +43.8% |
| Q1 2022 | $1,736,000 | -54.6% | 23,900 | +1.3% | 0.02% | -61.0% |
| Q2 2021 | $3,822,000 | +120.4% | 23,600 | -26.0% | 0.04% | +78.3% |
| Q4 2020 | $1,734,000 | +688.2% | 31,880 | +179.1% | 0.02% | +27.8% |
| Q4 2017 | $220,000 | -1.3% | 11,424 | +9.4% | 0.02% | -64.0% |
| Q2 2016 | $223,000 | – | 10,443 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |